Cargando…

P1311: GRANULOCYTE COLONY-STIMULATING FACTOR MOBILIZATION FACILITATES ANTI-GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA EFFECTS OF MUCOSA-ASSOCIATED INVARIANT T CELLS THROUGH DISTINCT FUNCTIONAL SUBSE

Detalles Bibliográficos
Autores principales:	Gao, M., Sun, Y., Kong, J., Chang, Y., Wang, Y., Huang, X., Zhao, X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429657/ http://dx.doi.org/10.1097/01.HS9.0000848108.18059.86

Ejemplares similares

Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease
por: Xuan, Li, et al.
Publicado: (2011)

Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation
por: Minculescu, Lia, et al.
Publicado: (2021)

The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
por: Gao, Meng-Ge, et al.
Publicado: (2021)

Granulocyte, granulocyte–macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells
por: Pei, X-H, et al.
Publicado: (1999)

Graft versus host disease diagnosis through biopsy of the oral mucosa lesions
por: Maia, Alexandre Pinto, et al.
Publicado: (2015)

Allogeneic Hematopoietic Stem Cell Transplantation Mobilized With Pegylated Granulocyte Colony-Stimulating Factor Ameliorates Severe Acute Graft-Versus-Host Disease Through Enrichment of Monocytic Myeloid-Derived Suppressor Cells in the Graft: A Real World Experience
por: Li, Lin, et al.
Publicado: (2021)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
por: Kim, Sena, et al.
Publicado: (2020)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
por: Dekker, Linde, et al.
Publicado: (2022)

Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease
por: Franklin, Cindy, et al.
Publicado: (2015)

P1311: LONG-TERM SAFETY AND EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS AS EARLY SECOND-LINE TREATMENT FOR PATIENTS WITH STEROID-DEPENDENT OR REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE.
por: Gavriilaki, Eleni, et al.
Publicado: (2023)

The Effect of Granulocyte Colony-Stimulating Factor (G-CSF) on Early Complications and Graft-Versus-Host Disease (GVHD) in Allogeneic Stem Cell Transplantation (ASCT) Recipients
por: Aydın Kaynar, Lale, et al.
Publicado: (2023)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity
por: Chin, D W L, et al.
Publicado: (2016)

The Graft-Versus-Leukemia Effect in AML
por: Sweeney, Connor, et al.
Publicado: (2019)

Diverse Activity of IL-17(+) Cells in Chronic Skin and Mucosa Graft-Versus-Host Disease
por: Klimczak, Aleksandra, et al.
Publicado: (2019)

Neuropathology of 16p13.11 Deletion in Epilepsy
por: Liu, Joan Y. W., et al.
Publicado: (2012)

Alloreactivity of Virus-Specific T Cells: Possible Implication of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effects
por: Fuji, Shigeo, et al.
Publicado: (2013)

IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects
por: Liu, Yuejun, et al.
Publicado: (2014)

Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
por: Karadimitris, Anastasios, et al.
Publicado: (2019)

COLLABORATION AGREEMENT No. K1311
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2006)

Granulocyte–macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD
por: Saha, S, et al.
Publicado: (2009)

Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts
por: Zhao, Xiang-Yu, et al.
Publicado: (2015)

Use of nasal mucosa graft in tympanoplasty
por: Coelho, Sandro Barros, et al.
Publicado: (2020)

Granulocyte colony‐stimulating factor is not pathogenic in lupus nephritis
por: Gottschalk, Timothy A., et al.
Publicado: (2021)

Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
por: Mavers, Melissa, et al.
Publicado: (2017)

Corneal perforation in ocular graft-versus-host disease
por: Zhang, Cathy Y., et al.
Publicado: (2021)

The Role of Pattern-Recognition Receptors in Graft-Versus-Host Disease and Graft-Versus-Leukemia after Allogeneic Stem Cell Transplantation
por: Heidegger, Simon, et al.
Publicado: (2014)

Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects
por: Meinhardt, Kathrin, et al.
Publicado: (2015)

HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect
por: Yao, Yushi, et al.
Publicado: (2017)

Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect
por: Huang, Ying, et al.
Publicado: (2022)

Histopathologic diagnosis of chronic graft-versus-host disease of the oral mucosa according to the National Institutes of Health Consensus
por: da Silva Santos, Paulo Sérgio, et al.
Publicado: (2014)

Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvement
por: Kaurinovic, Martina, et al.
Publicado: (2022)

Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate
por: Han, Jingjing, et al.
Publicado: (2017)

Autonomous production of granulocyte-colony stimulating factor in tumour xenografts associated with leukocytosis.
por: Katoh, Y., et al.
Publicado: (1993)

Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma
Publicado: (1995)

P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
por: Shimoni, A., et al.
Publicado: (2022)

Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models
por: Mashima, Kiyomi, et al.
Publicado: (2021)

Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
por: Haring, Eileen, et al.
Publicado: (2020)

Acute graft versus host disease
por: Jacobsohn, David A, et al.
Publicado: (2007)

Graft-versus-host Reactions in the Rabbit
por: Porter, K. A.
Publicado: (1960)

Cannot write session to /tmp/vufind_sessions/sess_5hbl1n1bsc2hjo9rv665e5e1g7